A Qualitative Study of Patient and Healthcare Provider Perspectives on Mobile Health Assessments for Cervical Spondylotic Myelopathy

This qualitative study of 15 patients and 14 healthcare providers reveals that while current tools for monitoring cervical spondylotic myelopathy are inadequate, stakeholders recognize significant potential for smartphone-based mobile health assessments to improve care, provided they feature intuitive design, seamless electronic medical record integration, and broad accessibility.

The Gist

Imagine you have a car that's starting to make a weird noise. You take it to the mechanic, but they only get to see the car for 15 minutes once a year. During that short visit, the car runs perfectly fine. But in between visits, the engine is sputtering, the brakes are getting sticky, and the dashboard lights are flickering. The mechanic has no idea what's happening in the real world, so they can't tell you if you need a new engine or just a tune-up.

This is exactly the problem doctors face with Cervical Spondylotic Myelopathy (CSM). It's a condition where the neck bones slowly squeeze the spinal cord, causing trouble with walking, hand coordination, and balance.

Here is the story of this paper, broken down into simple concepts:

1. The Problem: The "Snapshot" vs. The "Movie"

Currently, doctors diagnose and monitor CSM using tools that are like taking a single photograph.

• The Old Way: Patients fill out questionnaires (like "How is your hand feeling?") or do a quick test in the clinic (like walking a few steps).
• The Flaw: These are "snapshots." They happen once a year in a sterile clinic. But CSM is a "movie" that plays out 24/7 at home. Patients often forget how bad their symptoms are between visits, or they might be nervous in the clinic and perform better than usual.
• The Result: Doctors are flying blind. They don't know if the patient is slowly getting worse, staying the same, or having a bad day. This makes it hard to decide if surgery is needed.

2. The Solution: The "Fitness Tracker" for the Spine

The researchers wanted to build a smartphone app (called SynapTrack) that acts like a fitness tracker, but instead of counting steps, it measures how well your brain and spinal cord are talking to your hands and feet.

They asked two groups of people: Patients (the drivers) and Doctors (the mechanics). They wanted to know: Would you use this? Would it help? What would stop you?

3. What the Doctors Said (The Mechanics)

The doctors were very honest. They said, "We love the idea, but we have some worries."

• The "Blurry Photo" Problem: They admitted their current tools are too vague. One doctor said, "We need precision medicine, not just guessing." They want to see a graph of the patient's progress over time, similar to how a diabetic patient looks at their blood sugar levels (HbA1c) to manage diabetes.
• The "Borderline" Dilemma: The hardest cases are the ones where it's not clear if surgery is needed. Doctors said this app could be the tie-breaker. If the data shows the patient is slowly slipping, they can operate sooner. If the data is stable, they can wait.
• The "Clunky Interface" Fear: Since CSM affects hand dexterity, doctors worried, "If their hands are shaking, how will they type on a phone?" They also worried about the app being too complicated to fit into their busy day. They want the data to automatically pop up in their computer system, not on a separate website they have to log into.

4. What the Patients Said (The Drivers)

The patients were surprisingly enthusiastic.

• The "Mental Note" Struggle: Most patients were just keeping "mental notes" or writing things down in a notebook when they dropped something. They felt anxious not knowing if they were getting worse.
• The Desire for Control: They loved the idea of seeing a graph of their own progress. One patient said, "I want to see how I stack up over the week." It gives them peace of mind.
• Keep it Simple: They didn't want a video game or complex challenges. They said, "The simpler, the better." They just wanted clear instructions and a gentle reminder (like a text message) to do the test.

5. The Big Takeaway: Building a Bridge

The study concluded that while the technology is promising, we can't just build the app and throw it at people. We need to build a bridge between the tech and the real world.

To make this work, the app needs to be:

• Easy to use: Big buttons, clear text, and forgiving of shaky hands.
• Seamless: It must talk directly to the doctor's computer (Electronic Medical Record) so the doctor doesn't have to do extra work.
• Fair: It needs to work for everyone, including those who might not have the latest phone or live in areas with bad internet.

The Bottom Line

Think of this study as the blueprint phase for a new tool. The doctors and patients have agreed that the current way of checking on spinal cord health is like checking the weather by looking out the window once a year. They want a live weather radar on their phone that tells them exactly what's happening, every day, so they can make better decisions about their health.

The researchers are now using this feedback to build an app that is actually useful, easy to use, and ready for the real world.

Technical Summary

1. Problem Statement

Cervical Spondylotic Myelopathy (CSM) is the leading cause of spinal cord dysfunction in older adults, characterized by progressive degeneration and compression of the cervical spinal cord. Despite its prevalence, the clinical management of CSM faces significant challenges:

• Lack of Objective Metrics: Current monitoring relies heavily on patient-reported outcomes (e.g., mJOA scale, Neck Disability Index) and subjective clinical examinations. These tools lack sensitivity to subtle neurological changes and fail to quantify objective disability.
• Inter-rater Variability: Clinical assessments vary significantly between providers, leading to inconsistent diagnoses and difficulty in tracking progression.
• The "Clinic vs. Home" Gap: Traditional assessments capture only a snapshot of function during a clinic visit, failing to reflect real-world functional performance or daily fluctuations.
• Recall Bias: Patients often inaccurately recall symptom progression or functional decline over time.
• Limited mHealth Adoption: While mobile health (mHealth) has shown promise in other neurodegenerative conditions (e.g., Parkinson's, MS), its application in neurosurgery and CSM remains underdeveloped due to a lack of user-centered design and understanding of stakeholder needs.

2. Methodology

The study employed a qualitative research design using semi-structured interviews to gather stakeholder perspectives prior to the full deployment of a specific mHealth application (SynapTrack).

• Participants:
  • Patients: 15 individuals diagnosed with CSM recruited from Washington University in St. Louis. Exclusion criteria included other neurodegenerative diseases or recent non-cervical spine surgery.
  • Healthcare Providers: 14 providers (4 orthopedic surgeons, 5 physical therapists, 3 neurosurgeons, 2 occupational therapists) from academic, hospital, and private practice settings.
• Data Collection:
  • Patient Interviews: Conducted in a clinical lab after patients interacted with an early iteration of the SynapTrack app (a smartphone-based assessment tool using built-in sensors). Topics included symptoms, self-monitoring habits, and app usability.
  • Provider Interviews: Conducted via video conference. Topics covered current assessment workflows, limitations of existing tools, and attitudes toward mHealth integration.
• Data Analysis:
  • Interviews were transcribed and analyzed using thematic analysis following Braun and Clarke's six-step framework.
  • Two researchers independently coded data, with a third/fourth researcher reviewing for consensus.
  • Validation: Inter-rater reliability was assessed using Cohen's kappa. Initial validation showed moderate agreement (κ = 0.60), which improved to near-perfect agreement (κ = 0.90) after refining category definitions.

3. Key Contributions

This study provides the first in-depth exploration of stakeholder perspectives on mHealth specifically for CSM. Its primary contributions include:

• Identification of Unmet Needs: It systematically documents the specific failures of current assessment tools (e.g., mJOA) and the precise gaps mHealth must fill (longitudinal, objective, real-world data).
• User-Centered Design Requirements: It translates qualitative feedback into concrete design specifications for CSM apps, emphasizing the need for accessibility for patients with fine motor deficits.
• Implementation Framework: It outlines critical barriers to adoption, including Electronic Medical Record (EMR) integration, workflow efficiency, and equity concerns, providing a roadmap for successful clinical deployment.
• Stakeholder Alignment: It highlights the convergence and divergence between patient and provider priorities, showing that while both value objective data, patients prioritize simplicity and self-tracking, whereas providers prioritize surgical decision support and workflow integration.

4. Key Results

The analysis yielded two major themes for providers and two for patients.

Provider Perspectives

• Theme 1: Limitations of Current Tools:
  • Providers expressed deep dissatisfaction with the mJOA scale, citing it as inadequate for "precision medicine."
  • Current methods suffer from high inter-rater variability and an inability to capture subtle, real-world functional decline (e.g., dropping objects, handwriting changes).
  • There is a critical need for continuous, reproducible measures to distinguish between stable mild cases and progressive ones, particularly for surgical timing.
• Theme 2: Opportunities and Integration Challenges:
  • Opportunities: mHealth is viewed as a tool to monitor "borderline" cases, reduce patient anxiety through self-tracking, and provide data analogous to Hemoglobin A1C trends in diabetes.
  • Barriers:
    • Usability: Concerns that patients with myelopathy (fine motor impairment) may struggle with smartphone interfaces.
    • Workflow: Data must be integrated directly into EMRs; standalone apps create fragmentation.
    • Equity: Socioeconomic barriers (lack of devices, safe walking areas) could exclude vulnerable populations.
    • Data Interpretation: Clinicians need actionable insights (visualizations like line graphs) rather than raw data dumps to avoid "alarm fatigue."

Patient Perspectives

• Theme 1: Current Monitoring: Patients currently rely on informal methods (mental notes, observing daily activities like walking or sleeping) and often lack confidence in their ability to track progression accurately.
• Theme 2: Response to SynapTrack:
  • High Willingness: 14/15 patients expressed willingness to use the app daily, primarily in the morning at home.
  • Design Preferences: Patients prioritized simplicity over gamification. They requested larger text, simplified instructions, and clear guidance on whether to prioritize speed or accuracy.
  • Feedback Loop: Patients valued seeing their own progress trends over time but explicitly rejected comparing themselves to other users.
  • Adherence: Notifications (email/text) were seen as essential for maintaining routine.

5. Significance and Future Directions

• Clinical Impact: The study validates the potential for mHealth to transform CSM care from episodic, subjective assessments to continuous, objective monitoring. This could lead to earlier detection of progression and more informed surgical decision-making.
• Design Implications: The findings dictate that future CSM apps must be designed with accessibility as a core feature (accommodating motor deficits) and must integrate seamlessly into clinical workflows (EMR integration) to ensure provider adoption.
• Equity: The study underscores the necessity of addressing the "digital divide" to ensure mHealth tools do not exacerbate health disparities among CSM patients.
• Next Steps: The authors recommend longitudinal trials to evaluate the actual usability, adherence, and clinical validity of these tools in diverse practice settings, moving beyond stated preferences to observed behavior.

In conclusion, this paper establishes a foundational framework for developing SynapTrack and similar digital biomarkers, ensuring they are clinically relevant, user-friendly, and capable of addressing the specific, unmet needs of the CSM community.